Brenntag (OTCMKTS:BNTGY – Get Free Report) was upgraded by equities research analysts at Barclays to a “hold” rating in a report issued on Thursday,Zacks.com reports.
Other research analysts have also recently issued research reports about the stock. Citigroup restated a “neutral” rating on shares of Brenntag in a research note on Friday, November 14th. Morgan Stanley cut Brenntag from an “equal weight” rating to an “underweight” rating in a report on Tuesday, January 6th. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Brenntag in a research report on Wednesday, September 24th. Zacks Research raised Brenntag from a “strong sell” rating to a “hold” rating in a research note on Friday, October 17th. Finally, UBS Group downgraded Brenntag from a “hold” rating to a “sell” rating in a research note on Friday, October 10th. Six investment analysts have rated the stock with a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $12.80.
Get Our Latest Research Report on BNTGY
Brenntag Stock Down 3.5%
Brenntag (OTCMKTS:BNTGY – Get Free Report) last released its earnings results on Wednesday, November 12th. The company reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.01). Brenntag had a return on equity of 9.14% and a net margin of 2.66%.The firm had revenue of $4.31 billion for the quarter, compared to the consensus estimate of $4.32 billion. On average, equities research analysts expect that Brenntag will post 0.9 earnings per share for the current fiscal year.
Brenntag Company Profile
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
Featured Stories
- Five stocks we like better than Brenntag
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.
